Silence Therapeutics Begins Exclusive Nasdaq Trading
November 30, 2021 07:00 ET
|
Silence Therapeutics plc
Silence Therapeutics Begins Exclusive Nasdaq Trading 30 November 2021 LONDON, Silence Therapeutics plc, Nasdaq:SLN ("Silence" or "the Company"), a leader in the discovery, development and...
Silence Therapeutics to Present at Jefferies London Healthcare Conference
November 11, 2021 07:00 ET
|
Silence Therapeutics plc
Silence Therapeutics to Present at Jefferies London Healthcare Conference 11 November 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN (“Silence” or “the Company”), a leader in the...